BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30679392)

  • 1. Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study.
    Oh JK; Choi HY; Han M; Lee JK; Min KJ; Ki M
    Sex Transm Infect; 2019 Jun; 95(4):292-299. PubMed ID: 30679392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of HPV related anogenital diseases in young women in Germany - an analysis of German statutory health insurance claims data from 2012 to 2017.
    Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Braun S; Greiner W; Hampl M
    BMC Infect Dis; 2020 Apr; 20(1):297. PubMed ID: 32321435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
    Ki M; Choi HY; Han M; Oh JK
    Vaccine; 2018 Jul; 36(31):4633-4640. PubMed ID: 29961603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.
    Kim YT; Serrano B; Lee JK; Lee H; Lee SW; Freeman C; Oh JK; Alemany L; Bosch FX; Bruni L
    Papillomavirus Res; 2019 Jun; 7():26-42. PubMed ID: 30599280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital Wart and Human Papillomavirus Prevalence in Men in the United States From Penile Swabs: Results From National Health and Nutrition Examination Surveys.
    Daugherty M; Byler T
    Sex Transm Dis; 2018 Jun; 45(6):412-416. PubMed ID: 29750774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.
    Giuliano AR; Tortolero-Luna G; Ferrer E; Burchell AN; de Sanjose S; Kjaer SK; Muñoz N; Schiffman M; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 10(0 10):K17-28. PubMed ID: 18847554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
    Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
    Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
    Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.
    Hartwig S; St Guily JL; Dominiak-Felden G; Alemany L; de Sanjosé S
    Infect Agent Cancer; 2017; 12():19. PubMed ID: 28400857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
    Hansen BT; Campbell S; Nygård M
    BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Challenges in the implementation of HPV vaccination for cancer prevention].
    Rousseau S; Gaillot-de Saintignon J; Barret AS
    Rev Prat; 2019 May; 69(5):529-534. PubMed ID: 31626462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015.
    Park YJ; Kim JM; Lee BR; Kim TH; Lee EG
    Epidemiol Infect; 2018 Jan; 146(2):177-186. PubMed ID: 29235433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POP-Brazil study protocol: a nationwide cross-sectional evaluation of the prevalence and genotype distribution of human papillomavirus (HPV) in Brazil.
    Wendland EM; Caierão J; Domingues C; Maranhão AGK; de Souza FMA; Hammes LS; Falavigna M; Hilgert JB; Hugo FN; Bessel M; Villa LL; Benzaken AS
    BMJ Open; 2018 Jun; 8(6):e021170. PubMed ID: 29880568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.